Non-Invasive Fat Reduction With Cryolipolysis for Jawline Contouring
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Body Fat Disorder
- Sponsor
- Zeltiq Aesthetics
- Enrollment
- 15
- Locations
- 1
- Primary Endpoint
- Number of Participants With Unanticipated Adverse Device Effects (UADE)
- Status
- Completed
- Last Updated
- 9 months ago
Overview
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of non-invasive reduction of subcutaneous fat along the jawline with Cryolipolysis.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Number of Participants With Unanticipated Adverse Device Effects (UADE)
Time Frame: Enrollment through study completion, an average of 6 months.
This outcome measurement considered all unanticipated device- or procedure-related adverse effects.
Number of Before and After Side-by-side Photograph Pairs Correctly Identified by At Least 2 of 3 Blinded, Independent Reviewers
Time Frame: Baseline through 12 weeks post second treatment.
Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment (baseline) and post-treatment images of the treated areas. Reviewers will be practicing dermatologists or plastic surgeons. All reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which photographs will be presented will be randomized; for each subject placement of the baseline and pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form. Success is defined as 75% correct identification of pre-treatment photos by 2 out of 3 reviewers.
Secondary Outcomes
- Change in Fat Layer in the Treated Jawline Area(Baseline and 12 weeks post-final treatment.)
- Overall Satisfaction With the Treatment(12-week post-final treatment follow-up visit)